Posted on 5/5/17
Biohaven Prices IPO of Common Shares
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced the pricing of its initial public offering of 9,900,000 of its common shares at an initial public . . .
Posted on 5/5/17
Spero Therapeutics Receives Grant from National Institutes of Health
Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced that it has received a grant from . . .
Posted on 5/5/17
Agenus Provides Corporate Update
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies and cancer vaccines, provided a corporate update and reported financial results . . .
Posted on 5/5/17
Akebia Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), . . .
Posted on 5/3/17
IDEXX Laboratories Announces Increase in Share Repurchase Program
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced that the repurchase by the Company . . .
Posted on 5/3/17
DiversityInc Recognizes CVS Health on List of "Top 50 Companies for Diversity"
CVS Health (NYSE: CVS) today announced that it earned a place on DiversityInc's 2017 Top 50 Companies for Diversity list for the first time after several . . .
Posted on 5/3/17
Gelesis Announces €2.9 Million Award from Italian Ministry of Economic Development
BOSTON--(BUSINESS WIRE)--Gelesis, a biotechnology company developing a novel hydrogel platform to treat obesity and other chronic diseases related to the gastrointestinal (GI) pathway, today announced that . . .
Posted on 5/4/17
ECAN Petitions FDA for New Labels on Over-the-Counter Reflux Medications Warning about the Risk of Esophageal Cancer
BALTIMORE– One American dies of esophageal cancer every 36 minutes and the type of esophageal cancer caused by reflux disease is the fastest increasing cancer among . . .
Posted on 5/3/17
Lantheus Holdings Announces Public Secondary Offering
NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ:LNTH), today announced an agreement to sell 3,000,000 shares of its common stock to be offered by certain of its existing . . .
Posted on 5/3/17
Aetna (AET) Q1 2017 Results - Earnings Call Transcript
Aetna, Inc. (NYSE:AET)Q1 2017 Earnings CallMay 02, 2017 8:30 am ETExecutivesJoseph F. Krocheski - Aetna, Inc.Mark T. Bertolini - Aetna, Inc.Shawn M. Guertin - Aetna, Inc.Karen . . .
Posted on 5/3/17
BioAxone BioSciences Continues Plans for Growth with Manufacturing Contract
CAMBRIDGE, Mass.--(BUSINESS WIRE)--BioAxone BioSciences, Inc., a clinical-stage biotechnology company focused on developing innovative drugs to restore neurological function, today announced it has entered a contract with . . .
Posted on 5/3/17
Acceleron Announces Management Change
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ: XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to treat serious and . . .
Posted on 5/3/17
GI Dynamics Selects Allenby Capital to Explore AIM Listing Option
BOSTON & SYDNEY--(BUSINESS WIRE)--GI Dynamics®, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with . . .
Posted on 5/2/17
Bristol-Myers Squibb Outshines Merck And Pfizer
My go to place for initial research into a stock is the Dividend Champion spreadsheet maintained by David Fish. It is incredibly helpful for beginner and . . .
Posted on 5/2/17
Biohaven Pharmaceuticals Seeks $125 Million IPO
Quick TakeClinical stage biopharmaceutical company Biohaven Pharmaceuticals (Pending:BHVN) has filed to raise $125 million in an IPO by selling 8.33 million common shares at a midpoint . . .
Posted on 5/2/17
Cognex (CGNX) Q1 2017 Results - Earnings Call Transcript
Cognex Corp. (NASDAQ:CGNX)Q1 2017 Earnings CallMay 01, 2017 5:00 pm ETExecutivesJohn J. Curran - Cognex Corp.Dr. Robert J. Shillman - Cognex Corp.Robert J. Willett - Cognex . . .
Posted on 5/2/17
How Much Would Sarepta Therapeutics Fetch in a Buyout?
Sarepta Therapeutics (NASDAQ:SRPT) stock ended last week up over 11% due to the better-than-expected first-quarter sales of its Duchenne muscular dystrophy (DMD) drug Exondys 51, combined . . .
Posted on 5/2/17
AG Mednet Launches Endpoint Adjudication Technology to Ensure Data Quality
AG Mednet continues its drive to advance clinical trials with the launch of Judi, the first comprehensive electronic endpoint adjudication system to manage workflow and ensure . . .
Posted on 5/1/17
Peak Physical Therapy & Sports Performance Presents at the Scituate Science Spectacular
Eric Edelman, PT, owner of Peak Physical Therapy & Sports Performance demonstrates safe lifting technique while Maria O’Laughlin, PT demonstrates the movement of the spine.Peak Physical . . .
Posted on 5/1/17
Athenahealth, Inc. Disappoints in Q1 With Slow Sales Growth
Healthcare technology provider athenahealth (NASDAQ:ATHN) saw its sales growth cool off a bit in the fourth quarter of 2016. Its once high-flying stock isn't as hot . . .
Posted on 5/1/17
What's Worrying Me About Biogen
Biogen Inc. (NASDAQ:BIIB) recently reported its first-quarter financial results, and while the company remains the market share leader in multiple sclerosis (MS) treatment, there are signs . . .
Posted on 5/1/17
IDEXX Laboratories Announces First Quarter Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, reports revenues for the first quarter of 2017 . . .
Posted on 5/1/17
GenePeeks Announces Partnership with Fertility SOURCE Companies
CAMBRIDGE, Mass.--(BUSINESS WIRE)--GenePeeks, Inc., a computational genomics company focused on transforming genetic disease risk analysis, today announced a new partnership with Fertility SOURCE Companies® and its . . .
Posted on 4/29/17
Agios Closes Over-Allotment Option in Public Offering
CAMBRIDGE, Mass., April 28, 2017 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO) today announced that it has issued an additional 757,575 shares of common stock at . . .
Posted on 4/28/17
Bristol-Myers Squibb: Becoming An Increasingly Attractive Target
Bristol-Myers Squibb (NYSE:BMY) reported very positive first quarter results on Thursday morning, with revenues as well as earnings growing at an attractive pace. Earlier this year . . .
Boston
